Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XEN-D0501 in Chronic Idiopathic Cough
NCT02233699Phase 2Completed
- Sponsor
- Xention Ltd.
- Start
- Jul 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of XEN-D0501 in chronic idiopathic cough (CIC), sponsored by Xention Ltd.. Started Jul 2014; status: completed.
02
Drugs
XEN-D0501
03
Conditions
chronic idiopathic cough (CIC)
Beyond the preview
Go deeper on NCT02233699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02233699.